- Sector Ventures
Healthcare Investments
Univere Investment Solutions introduces qualified investors to healthcare investment opportunities structured as bonds and secured loan notes. These products are structured by trusted third parties and introduced to qualified investors through Univere.
originated and delivered
and market experience
value across strategies
global markets
What Healthcare Investment Opportunities Look Like at Univere
At Univere Investment Solutions, we provide certified and self-certified investors access to healthcare investment opportunities across specialist areas of the healthcare space. We introduce products built around real ventures, not financial instruments tied to an index.
We connect eligible investors with healthcare-focused structures at the pre-institutional stage. This includes high-net-worth individuals (HNWIs), ultra-high-net-worth individuals (UHNWIs), family offices and regulated advisors.
As a healthcare investment service, our role is to introduce and distribute products designed and issued by trusted third parties. We don’t manage client money, and we don’t provide financial advice.
Arrange a call with our team to discuss healthcare opportunities.
Why the Healthcare Sector Is Drawing Private Capital
The healthcare sector is attracting private capital because health systems face a funding gap that public budgets can’t close. In 2025, healthcare private equity dealmaking hit a record $191 billion, according to Bain & Company’s Global Healthcare Private Equity Report 2026.
In the UK, the NHS spends around £10.7 billion a year on diabetes alone. Obesity adds a further £12 billion in direct NHS costs, with high-cost specialty drugs, particularly GLP-1 therapies, adding further pressure to pharmacy spend. Related costs across the wider economy are estimated at nearly £126 billion, according to research from Nesta and Frontier Economics.
The UK’s 10-Year Health Plan set the direction, and the Autumn Budget 2025 confirmed it. Private capital and public-private partnerships now help fund NHS neighbourhood health centers (NHCs). This shift reflects a broader pattern across global markets, as health systems increasingly rely on private partnerships and digital health platforms to expand access to care.
Demand for healthcare services isn’t tied to the economic cycle, giving this exposure a defensive quality few other sectors offer. At the same time, policy increasingly welcomes private capital, opening routes into projects once reserved for public funding.
The Healthcare Industry Opportunities We Introduce
The healthcare opportunities we introduce sit within specialist categories with growing clinical demand. Technology-led delivery models support this, giving patients more reliable access to treatment.
This includes direct-to-consumer models, which can lower drug costs and broaden patient access, as well as businesses that use AI to improve clinical workflows, automate routine tasks and enhance diagnostic accuracy. More broadly, healthcare investment activity is shaped by technological innovation, operational efficiency and rising pharmaceutical costs.
Univere’s assessment process includes research into each provider’s growth strategy and revenue model. We also review management track records before introducing any offering to the investor network.
How These Healthcare Investment Products Are Structured
These healthcare investment products are structured as bonds and secured loan notes, not equities or fund units. Each is issued by the relevant third party, with capital directed at the specific venture behind the structure.
Where applicable, these structures are backed by real, tangible assets or by the venture’s underlying business value and performance. Where a structure is asset-backed, capital is secured against the project rather than on the issuer’s general credit alone. This security relates to the investment’s underlying asset; it doesn’t guarantee the return of capital, which remains at risk.
Assessing a complex sector like healthcare requires more than a single data point. The table below sets out how a structured healthcare investment product compares with a direct holding in a listed healthcare company.
Feature | Direct holdings in listed healthcare companies | Healthcare investment products via Univere |
Structure | Shares, exchange-traded funds (ETFs) or mutual funds | Bonds and secured loan notes |
Liquidity | Generally tradable on public markets | Limited, typically held to maturity |
Access | Retail and institutional | Certified and self-certified investors, structuring stage |
Return profile | Tied to market sentiment and share price | Linked to defined terms and venture performance |
Healthcare Investment Strategies Within a Broader Portfolio
Healthcare investment strategies can add long-term growth potential to a portfolio that would otherwise be concentrated in listed markets. Advisors typically assess this allocation alongside an investor’s wider objectives, risk tolerance and tax position.
Investors who work with qualified advisors sometimes hold exposure across multiple specialist sectors alongside listed holdings. Each of Univere’s sectors is served by separately structured products.
The amount an investor chooses to invest varies by product and eligibility. At Univere, we don’t advise on how a healthcare allocation should sit within a wider strategy. We introduce eligible investors to an advisor or a relevant third-party platform where one is required.
At Univere, we introduce real, underlying ventures behind every healthcare investment opportunity. This gives investors a single relationship providing access to multiple sectors, from healthcare to renewable energy and alternative assets.
Arrange a call with our team to discuss healthcare investment opportunities.
Frequently Asked Questions About Healthcare Investments
The questions below address the most common points raised during initial inquiries. Detailed offering materials, product terms and project-level information are available only after certification or self-certification, as required by regulation.
01
Who can access healthcare investment opportunities through Univere?
Access is limited to certified and self-certified high-net-worth individuals, sophisticated investors, family offices and regulated advisors. Each contact completes a certification step before receiving product-specific details, in line with the relevant financial promotion exemptions.
02
How does Univere differ from other healthcare investment firms?
Univere is an introducer and distributor, not a healthcare investment firm that manages assets directly. We connect qualified investors with structures designed by trusted third parties. This offers access at the structuring stage, rather than once a product has entered wider institutional or public markets.
03
What role does private market access play in healthcare allocation?
Private market access gives investors exposure to healthcare ventures that aren’t available on public markets. This differs from buying shares in listed healthcare providers, where pricing already reflects broad market sentiment.
04
Are returns guaranteed on healthcare investment products?
No. Capital remains at risk across all structured products we introduce, and returns aren’t guaranteed. Past performance isn’t indicative of future results. Every structure carries risks specific to the underlying venture, including execution, regulatory and market timing risk.
Changes to drug pricing rules and reimbursement policy can also meaningfully affect expected returns, and pricing dynamics are often shaped by the wider market strategies of pharmaceutical companies.
05
How does healthcare sit alongside Univere's other sectors?
Healthcare sits within Univere’s wider portfolio, alongside renewable energy, film finance and other specialist assets. This includes innovation, plus critical infrastructure and national resilience technology. Each sector is served by separately structured products, designed to align with a range of investment objectives. See our insights page for more information on structuring and capital allocation across these sectors.
Arrange a call with our team to discuss healthcare investment opportunities.
This content is directed solely at persons who qualify as high-net-worth individuals, sophisticated investors or regulated financial professionals under the Financial Promotion Order 2005. It doesn’t constitute financial advice or a recommendation. Capital is at risk. Investments may be illiquid and difficult to realize. Past performance isn’t indicative of future results. Tax treatment varies based on individual circumstances and may change. Prospective investors should seek independent financial and legal advice before making any investment decision. Univere Investment Solutions Limited isn’t authorized or regulated by the UK’s Financial Conduct Authority (FCA). This content doesn’t constitute a financial promotion, financial advice or an invitation or inducement to engage in investment activity.
